Pristanic acid

Pristanic acid is a lipid of Prenol Lipids (PR) class. Pristanic acid is associated with abnormalities such as Refsum Disease, Peroxisomal Disorders, Hereditary Diseases, Peripheral Neuropathy and Sensory neuropathy. The involved functions are known as physiological aspects, Regulation, Pathogenesis, Oxidation and Peroxisome Proliferator-activated Receptor Activity [MoA]. Pristanic acid often locates in peroxisome, Body tissue, Mitochondria, Membrane of peroxisome and Organelles. The associated genes with Pristanic acid are PSG5 gene, LGALS4 gene, PEX2 gene, ACSL4 gene and ACSL1 Gene. The related lipids are pristanic acid, Fatty Acids, branched chain fatty acid, Plasmalogens and 3-hydroxypristanic acid.

Cross Reference

Introduction

To understand associated biological information of Pristanic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Pristanic acid?

Pristanic acid is suspected in Peroxisomal Disorders, Refsum Disease, Protein Deficiency, Retinitis Pigmentosa, Enzyme Deficiency, Hereditary Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Pristanic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Refsum Disease D012035 19 associated lipids
Cholestasis D002779 23 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Peroxisomal Disorders D018901 5 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Chondrodysplasia Punctata D002806 8 associated lipids
Per page 10 20 | Total 14

PubChem Associated disorders and diseases

What pathways are associated with Pristanic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Pristanic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Pristanic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Pristanic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Pristanic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Pristanic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Pristanic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Pristanic acid

Download all related citations
Per page 10 20 50 100 | Total 141
Authors Title Published Journal PubMed Link
pmid:
Steinberg SJ et al. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. 1999 Biochem. Biophys. Res. Commun. pmid:10198260
Ferdinandusse S et al. Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta-oxidation of branched-chain fatty acids. 1999 Biochem. Biophys. Res. Commun. pmid:10486279
Wanders RJ et al. Lipid metabolism in peroxisomes: enzymology, functions and dysfunctions of the fatty acid alpha- and beta-oxidation systems in humans. 2000 Biochem. Soc. Trans. pmid:10816116
Zomer AW et al. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. 2000 J. Lipid Res. pmid:11060349
Ferdinandusse S et al. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. 2000 J. Lipid Res. pmid:11060359
Ferdinandusse S et al. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency. 2001 J. Lipid Res. pmid:11160375
Jansen GA et al. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes. 2001 Biochem. Biophys. Res. Commun. pmid:11341778
pmid:11356170
pmid:11356171
Van Veldhoven PP et al. Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency. 2001 Eur. J. Clin. Invest. pmid:11473573
Verhoeven NM and Jakobs C Human metabolism of phytanic acid and pristanic acid. 2001 Prog. Lipid Res. pmid:11591435
Hunt MC et al. Characterization of an acyl-coA thioesterase that functions as a major regulator of peroxisomal lipid metabolism. 2002 J. Biol. Chem. pmid:11673457
Ofman R et al. Demonstration of dimethylnonanoyl-CoA thioesterase activity in rat liver peroxisomes followed by purification and molecular cloning of the thioesterase involved. 2002 Biochem. Biophys. Res. Commun. pmid:11785945
McLean BN et al. A new defect of peroxisomal function involving pristanic acid: a case report. 2002 J. Neurol. Neurosurg. Psychiatr. pmid:11861706
Ferdinandusse S et al. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders. 2002 J. Lipid Res. pmid:11893780
Schluter A et al. Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation. 2002 FEBS Lett. pmid:12062414
Idel S et al. Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells. 2002 J. Biol. Chem. pmid:12368296
Gootjes J et al. Biochemical markers predicting survival in peroxisome biogenesis disorders. 2002 Neurology pmid:12473763
Setchell KD et al. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. 2003 Gastroenterology pmid:12512044
pmid:12814641
ten Brink HJ et al. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata. 1992 Pediatr. Res. pmid:1282700
Straube R et al. Membrane differential filtration is safe and effective for the long-term treatment of Refsum syndrome--an update of treatment modalities and pathophysiological cognition. 2003 Transfus. Apher. Sci. pmid:12877898
Mobley JA et al. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. 2003 Cancer Epidemiol. Biomarkers Prev. pmid:12917210
ten Brink HJ et al. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography. 1992 J. Lipid Res. pmid:1372637
Chow CW et al. Autopsy findings in two siblings with infantile Refsum disease. 1992 Acta Neuropathol. pmid:1373019
ten Brink HJ et al. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders. 1992 J. Lipid Res. pmid:1385561
Wanders RJ et al. Activation and oxidation of pristanic acid in rat liver: identification of a distinct, clofibrate non-inducible pristanoyl-CoA oxidase. 1992 Prog. Clin. Biol. Res. pmid:1438370
Wanders RJ et al. Molecular analysis of disorders of peroxisomal beta-oxidation. 1992 Prog. Clin. Biol. Res. pmid:1438395
Johnson DW et al. Measurement of plasma pristanic, phytanic and very long chain fatty acids by liquid chromatography-electrospray tandem mass spectrometry for the diagnosis of peroxisomal disorders. 2003 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:14630371
Singh I et al. Phytanic acid alpha-oxidation in human cultured skin fibroblasts. 1992 Biochim. Biophys. Acta pmid:1463774
Singh H et al. Peroxisomal beta-oxidation of branched chain fatty acids in human skin fibroblasts. 1992 J. Lipid Res. pmid:1464743
Gootjes J et al. Biochemical markers predicting survival in peroxisome biogenesis disorders. 2003 Adv. Exp. Med. Biol. pmid:14713214
Zomer AW et al. Phytanic and pristanic acid are naturally occuring ligands. 2003 Adv. Exp. Med. Biol. pmid:14713238
Atshaves BP et al. Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice. 2004 J. Lipid Res. pmid:14993239
Westin MA et al. Molecular cloning and characterization of two mouse peroxisome proliferator-activated receptor alpha (PPARalpha)-regulated peroxisomal acyl-CoA thioesterases. 2004 J. Biol. Chem. pmid:15007068
van den Brink DM et al. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid. 2004 Mol. Genet. Metab. pmid:15110319
Peduto A et al. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders. 2004 Mol. Genet. Metab. pmid:15234336
Clarke CE et al. Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. 2004 Neurology pmid:15249642
pmid:15574183
pmid:15644212
Gloerich J et al. A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARalpha-dependent and -independent pathways. 2005 J. Lipid Res. pmid:15654129
Atshaves BP et al. Effect of branched-chain fatty acid on lipid dynamics in mice lacking liver fatty acid binding protein gene. 2005 Am. J. Physiol., Cell Physiol. pmid:15692150
Wanders RJ et al. Characteristics and subcellular localization of pristanoyl-CoA synthetase in rat liver. 1992 Biochim. Biophys. Acta pmid:1596515
Roe DS et al. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts. 2006 Mol. Genet. Metab. pmid:16297647
Huyghe S et al. Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice. 2006 Endocrinology pmid:16484321
Ferdinandusse S et al. Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. 2006 Am. J. Hum. Genet. pmid:16685654
pmid:16773508
Gloerich J et al. Metabolism of phytol to phytanic acid in the mouse, and the role of PPARalpha in its regulation. 2007 J. Lipid Res. pmid:17015885
Atshaves BP et al. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism. 2007 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17068117
ten Brink HJ et al. Pristanic acid and phytanic acid in plasma from patients with a single peroxisomal enzyme deficiency. 1991 J. Inherit. Metab. Dis. pmid:1722861
Dahlgren J et al. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. 2007 Environ Health pmid:17316448
Villarroya F et al. PPARs in the Control of Uncoupling Proteins Gene Expression. 2007 PPAR Res pmid:17389766
Fraccascia P et al. Presence of thiamine pyrophosphate in mammalian peroxisomes. 2007 BMC Biochem. pmid:17596263
Westin MA et al. Peroxisomes contain a specific phytanoyl-CoA/pristanoyl-CoA thioesterase acting as a novel auxiliary enzyme in alpha- and beta-oxidation of methyl-branched fatty acids in mouse. 2007 J. Biol. Chem. pmid:17613526
ten Brink HJ et al. Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase. 1991 J. Inherit. Metab. Dis. pmid:1779614
pmid:17956234
pmid:17956235
Thompson SA et al. Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. 2008 J. Neurol. Neurosurg. Psychiatr. pmid:18032455
pmid:18077198
Schrader M and Fahimi HD The peroxisome: still a mysterious organelle. 2008 Histochem. Cell Biol. pmid:18274771
Al-Dirbashi OY et al. Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders. 2008 J. Lipid Res. pmid:18441019
pmid:18536048
Zheng BS et al. Arabidopsis sterol carrier protein-2 is required for normal development of seeds and seedlings. 2008 J. Exp. Bot. pmid:18687588
Kase BF et al. Separation of phytanic and pristanic acid by high-pressure liquid chromatography: application of the method. 1991 Anal. Biochem. pmid:1888042
pmid:19005174
Krause C et al. Rational diagnostic strategy for Zellweger syndrome spectrum patients. 2009 Eur. J. Hum. Genet. pmid:19142205
Mackie JT et al. Phytol-induced hepatotoxicity in mice. 2009 Toxicol Pathol pmid:19188468
Rönicke S et al. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes. 2009 Neurobiol. Dis. pmid:19703563
Guo XR et al. The sterol carrier protein 2/3-oxoacyl-CoA thiolase (SCPx) is involved in cholesterol uptake in the midgut of Spodoptera litura: gene cloning, expression, localization and functional analyses. 2009 BMC Mol. Biol. pmid:19912624
García-Rojas P et al. Induction of peroxisomal proliferator-activated receptor gamma and peroxisomal proliferator-activated receptor gamma coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue1,2. 2010 J. Anim. Sci. pmid:20154154
pmid:20388135
Pyper SR et al. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. 2010 Nucl Recept Signal pmid:20414453
Wanders RJ et al. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results. 2010 J. Inherit. Metab. Dis. pmid:20490924
Van Veldhoven PP Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. 2010 J. Lipid Res. pmid:20558530
Hao T et al. Compartmentalization of the Edinburgh Human Metabolic Network. 2010 BMC Bioinformatics pmid:20649990
Smith EH et al. An adult onset case of alpha-methyl-acyl-CoA racemase deficiency. 2010 J. Inherit. Metab. Dis. pmid:20821052
Astarita G et al. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. 2010 PLoS ONE pmid:20838618
Kapina V et al. Relapsing rhabdomyolysis due to peroxisomal alpha-methylacyl-coa racemase deficiency. 2010 Neurology pmid:20921516
Watkins PA et al. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. 2010 BMC Physiol. pmid:20932325
Leipnitz G et al. Pristanic acid promotes oxidative stress in brain cortex of young rats: a possible pathophysiological mechanism for brain damage in peroxisomal disorders. 2011 Brain Res. pmid:21241675
Sevin C et al. Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. 2011 Orphanet J Rare Dis pmid:21392394
Busanello EN et al. Neurochemical evidence that pristanic acid impairs energy production and inhibits synaptic Na(+), K(+)-ATPase activity in brain of young rats. 2011 Neurochem. Res. pmid:21445584
Kemp S et al. Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. 2011 Br. J. Pharmacol. pmid:21488864
Kruska N and Reiser G Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40. 2011 Neurobiol. Dis. pmid:21570468
Kou J et al. Peroxisomal alterations in Alzheimer's disease. 2011 Acta Neuropathol. pmid:21594711
Werner LB et al. Effect of dairy fat on plasma phytanic acid in healthy volunteers - a randomized controlled study. 2011 Lipids Health Dis pmid:21663648
Wanders RJ et al. Phytanic acid metabolism in health and disease. 2011 Biochim. Biophys. Acta pmid:21683154
Thompson SA et al. Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency. 2009 BMJ Case Rep pmid:21686617
Rizzo WB The role of fatty aldehyde dehydrogenase in epidermal structure and function. 2011 Dermatoendocrinol pmid:21695018
Terre'Blanche G et al. Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report. 2011 Lipids Health Dis pmid:21871076
Steinberg D Chance and serendipity in science: two examples from my own career. 2011 J. Biol. Chem. pmid:21908608
Busanello EN et al. Experimental evidence that pristanic acid disrupts mitochondrial homeostasis in brain of young rats. 2012 J. Neurosci. Res. pmid:22183871
Mamedov IS et al. [The diagnostic of peroxisomic diseases in children]. 2012 Klin. Lab. Diagn. pmid:22712285
Poulos A et al. Defective oxidation of pristanic acid by fibroblasts from patients with disorders in propionic acid metabolism. 1990 Clin. Genet. pmid:2311265
McMillan HJ et al. Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency. 2012 Orphanet J Rare Dis pmid:23181892
Klein CJ et al. Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion. 2013 Nutr Clin Pract pmid:23319354
Busanello EN et al. Disruption of oxidative phosphorylation and synaptic Na(+), K(+)-ATPase activity by pristanic acid in cerebellum of young rats. 2014 Life Sci. pmid:24211616
Poulos A et al. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction. 1988 Eur. J. Pediatr. pmid:2452737
Wright ME et al. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers. 2014 Cancer Med pmid:25132681